Risk factors and prevention of breast cancer;Risikofaktoren und Prävention des Mammakarzinoms

Onkologe

Volumn 21, Issue 3, 2015, Pages 202-210

  Rhiem, K ^a   Schmutzler, R K ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; Preventive measures; Risk factors

Indexed keywords

EID: 84939960819     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-014-2837-5     Document Type: Article

References (30)

1. Krebs in Deutschland 2009/2010 (2013) 9. Ausgabe. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg). Berlin
2. Pettersson A, Graff RE, Ursin G et al (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 106(5). pii:dju078. doi:10.1093/jnci/dju078
3. Ingegnoli A, d’Aloia C, Frattaruolo A (2010) Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate. Breast J 16(1):55–59. doi:10.1111/j.1524-4741.2009.00850.x (Epub 2009 Oct 13)
4. Buist DS, Abraham LA, Barlow WE et al (2010) Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat 124:863–873
5. Ritte R, Lukanova A, Tjønneland A et al (2013) Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study. Int J Cancer 132(11):2619–2629 (Epub 2012 Nov 14)
6. Ritte R, Lukanova A, Berrino F et al (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 14(3):R76
7. Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses‘ Health Study. Am J Epidemiol 139:819–835
8. Collaborative Group on Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187–195
9. International Agency for Research on Cancer (2012) Some chemicals in industrial and consumer products, food contaminants and flavourings and water chlorination by-products: volume 100E, personal habits and indoor combustions. Lyon (France)
10. Chen WY, Rosner B, Hankinson SE et al (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306:1884–1890
11. Wu Y, Zhang D, Kang S (2013) Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 137:869–882
12. Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol 21(23):4386–4394
13. Schellong G, Riepenhausen M, Ehlert K et al (2014) Breast cancer in young women after treatment for Hodgkin’s disease during childhood or adolescence – an observational study with up to 33-year follow-up. Dtsch Arztebl Int 111(1–2):3–9. doi:10.3238/arztebl.2014.0003
14. Henderson TO, Amsterdam A, Bhatia S et al (2010) Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 152(7):444–455; W144–54. (Review)
15. Hodgson DC (2011) Late effects in the era of modern therapy for Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2011:323–329. doi:10.1182/asheducation-2011.1.323 (Review)
16. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676–689
17. Meindl A, Ditsch N, Kast K et al (2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 108:323–330
18. Antoniou AC, Beesley J, McGuffog L et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70:9742–9754
19. Meindl A, Hellebrand H, Wiek C et al (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42:410–414
20. Gevensleben H, Bossung V, Meindl A et al (2014) Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers. Virchows Arch 465(3):365–369. (Epub 2014 Jul 4)
21. Goldgar DE, Healey S, Dowty JG et al (2011) Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 13:R73
22. Graeser MK, Engel C, Rhiem K et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27:5887–5892
23. Rhiem K, Engel C, Graeser M et al (2012) The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast Cancer Res 14:R156
24. Bosse K, Rhiem K, Wappenschmidt B et al (2006) Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. Gynecol Oncol 103:1077–1082
25. King TA, Sakr R, Patil S et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29(16):2158–2164. (Epub 2011 Apr 4)
26. Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate – women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 14(1):25–32. doi:10.1111/j.1524-4741.2007.00521.x
27. Frost MH, Slezak JM, Tran NV et al (2005) Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23(31):7849–7856 (Epub 2005 Oct 3)
28. Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175–5180
29. Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304:967–975
30. Meijers-Heijboer H, Geel B van, Putten WL van et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 and BRCA2 mutation. N Engl J Med 345:159–164